M MENARINI STEMLINE ONCOLOGY Trademark

Trademark Overview


On Thursday, January 14, 2021, a trademark application was filed for M MENARINI STEMLINE ONCOLOGY with the United States Patent and Trademark Office. The USPTO has given the M MENARINI STEMLINE ONCOLOGY trademark a serial number of 79306524. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Saturday, February 26, 2022. This trademark is owned by A. MENARINI INDUSTRIE FARMACEUTICHE RIUNITE S.r.l.. The M MENARINI STEMLINE ONCOLOGY trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Diagnostic reagents for medical use; pharmaceutical preparations and substances for the treatment of cancer

Biomedical research services; pharmaceutical products development; design and testing of new products; testing of pharmaceuticals; medical and pharmacological research services; research and development in the pharmaceutical and biotechnology fields
m menarini stemline oncology

General Information


Serial Number79306524
Word MarkM MENARINI STEMLINE ONCOLOGY
Filing DateThursday, January 14, 2021
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateSaturday, February 26, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Description of MarkThe mark consists of an upper-case letter "M" outlined in black, the interior of the letter is white, the two right triangles formed by the bottom of the "M" are in the color red, and the large isosceles triangle formed at the top of the letter "M" is black and is bisected from bottom to top by the name "MENARINI" in upper-case lettering in white; on the right side of the letter "M" is the name "MENARINI" in black in upper-case lettering and the name "STEMLINE" in black in lower-case letting, with the upper-case letter "S"; beneath the letter "M" and the names "MENARINI" and "STEMLINE" is a black horizontal line, which is interrupted in the center by the name "ONCOLOGY" in black in Italic lettering.
Goods and ServicesDiagnostic reagents for medical use; pharmaceutical preparations and substances for the treatment of cancer
Pseudo MarkM MENARINI STEM LINE ONCOLOGY
Indication of Colors claimedThe color(s) red, black and white is/are claimed as a feature of the mark.
Goods and ServicesBiomedical research services; pharmaceutical products development; design and testing of new products; testing of pharmaceuticals; medical and pharmacological research services; research and development in the pharmaceutical and biotechnology fields

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, March 19, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, March 19, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameA. MENARINI INDUSTRIE FARMACEUTICHE RIUNITE S.r.l.
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressIT

Trademark Events


Event DateEvent Description
Tuesday, March 21, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, February 27, 2023FINAL DISPOSITION NOTICE SENT TO IB
Sunday, February 26, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, October 25, 2022NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, October 5, 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, October 5, 2022NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Monday, February 28, 2022ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Saturday, February 26, 2022ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Saturday, February 26, 2022ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Sunday, August 29, 2021REFUSAL PROCESSED BY IB
Thursday, August 12, 2021NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, August 12, 2021REFUSAL PROCESSED BY MPU
Sunday, August 1, 2021NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Saturday, July 31, 2021NON-FINAL ACTION WRITTEN
Tuesday, July 27, 2021ASSIGNED TO EXAMINER
Tuesday, May 4, 2021CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Saturday, May 1, 2021CORRECTION TRANSACTION RECEIVED FROM IB
Tuesday, March 23, 2021APPLICATION FILING RECEIPT MAILED
Friday, March 19, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, March 18, 2021LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, March 11, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB